Indeed, as Galectin-1 was recently reported to trigger EMT and tumor progression in human hepatocellular carcinoma [25], gastric cancer [26], and colon cancer [37], we hypothesized that it may also induce EMT in pancreatic cancer, which is the foundation of this research. This evidence concerns the gene LGALS1 and pancreatic neoplasm.